IMRNW (Immuron) PB Ratio: (As of Jul. 01, 2026)


What is Immuron PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-01), Immuron's share price is $0.0732. Immuron's Book Value per Share for the fiscal year that ended in Jun. 2025 was $0.00. Hence, Immuron's PB Ratio of today is .

Good Sign:

Immuron Ltd stock PB Ratio (=0.83) is close to 3-year low of 0.79.

The historical rank and industry rank for Immuron's PB Ratio or its related term are showing as below:

IMRNW' s PB Ratio Range Over the Past 10 Years
Min: 0.72   Med: 2.06   Max: 15.47
Current: 0.83

During the past 11 years, Immuron's highest PB Ratio was 15.47. The lowest was 0.72. And the median was 2.06.

IMRNW's PB Ratio is ranked better than
86.9% of 1229 companies
in the Biotechnology industry
Industry Median: 2.87 vs IMRNW: 0.83

During the past 12 months, Immuron's average Book Value Per Share Growth Rate was -11.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -30.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -5.60% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Immuron was 39.00% per year. The lowest was -30.70% per year. And the median was -10.10% per year.

Back to Basics: PB Ratio


Immuron  (NAS:IMRNW) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Immuron PB Ratio Related Terms


Immuron PB Ratio Historical Data

* Premium members only.

The historical data trend for Immuron's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immuron PB Ratio Chart

Immuron Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Immuron Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMRNW vs VRTX, REGN, ALNY: PB Ratio Comparison

For the Biotechnology subindustry, Immuron's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immuron PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuron's PB Ratio distribution charts can be found below:

* The bar in red indicates where Immuron's PB Ratio falls into.



Immuron PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Immuron's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (A: Jun. 2025)
=0.0732/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Immuron Business Description

Address 25-37, Chapman Street, Unit 10, Blackburn, Melbourne, VIC, AUS, 3130
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.